Drug-labels.com

Keflex: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Dormant
Strength:
125 mg, 250 mg, 500 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Keflex

What is KEFLEX® used for?

  • KEFLEX® is used to treat certain bacterial infections in the:

    • respiratory tract;
    • ear (otitis media);
    • genitals and urinary tract;
    • bones and joints;
    • skin and soft tissue.
  • Antibacterial drugs like KEFLEX® treat only bacterial infections. They do not treat viral infections, such as the common cold.

How does KEFLEX® work?

KEFLEX® is an antibiotic that:

  • Stops the growth of bacteria
  • Kills bacteria

What are the ingredients in KEFLEX®?

Medicinal ingredients: Cephalexin

Non-medicinal ingredients:

250 mg Tablets: Glycerin, Hydroxypropyl Methylcellulose, Starch, Magnesium Stearate, Methyl Cellulose, Pregelatinized Maize Starch, Red Iron Oxide, Sodium Starch Glycolate, Stearic Acid Powder, Talc, Titanium Dioxide and Yellow Iron Oxide.

500 mg Tablets: Glycerin, Hydroxypropyl Methylcellulose, Magnesium Stearate, Methyl Cellulose, Povidone, Red Iron Oxide, Sodium Starch Glycolate, Talc, Titanium Dioxide and Yellow Iron Oxide.

125 mg / 5 mL Oral Solution: FD&C Red No. 40, Imitation Guarana Flavour, Methylcellulose, Sodium Lauryl Sulfate, Sucrose Fine Granulated and Sucrose Silicone.

250 mg / 5 mL Oral Solution: FD&C Yellow No. 6, Imitation Guarana Flavour, Methylcellulose, Sodium Lauryl Sulfate, Sucrose Fine Granulated and Sucrose Silicone.

KEFLEX® comes in the following dosage forms:

250 mg Tablets: Supplied in bottles of 100 and 500 Tablets.

500 mg Tablets: Supplied in bottles of 100 and 250 Tablets.

125 mg / 5 mL Oral Suspension: Supplied in 100 and 200 mL bottles.

250 mg / 5 mL Oral Suspension: Supplied in 100 and 200 mL bottles.

Do not use KEFLEX® if:

  • you are allergic to cephalexin, cephalosporin antibiotics or to any of the other ingredients in KEFLEX®

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take KEFLEX®. Talk about any health conditions or problems you may have, including if you:

  • you are allergic to or react badly to penicillins or other antibiotics.
  • you have intestinal or bowl problems.
  • you have kidney problems.
  • you are pregnant or plan to be pregnant.

  • you are breast-feeding or plan to breast-feed.

Other warnings that you should know about:

  • Using antibiotics like KEFLEX® may cause with Clostridium difficile-associated disease (CDAD). See “Serious side effects and what to do about them”, below.
  • KEFLEX® may interfere with some blood and urine test results. Talk to your doctor if you are given a blood or urine test while taking KEFLEX®.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

How to take KEFLEX®:

  • Take KEFLEX® orally on an empty stomach.

  • Although you may feel better early in treatment, KEFLEX® should be used exactly as directed.
  • Misuse or overuse of KEFLEX® could lead to the growth of bacteria that will not be killed by KEFLEX® (resistance). This means that KEFLEX® may not work for you in the future.
  • Do not share your medicine.

Usual dose:

Adult:

The adult dosage ranges from 1 to 4 g daily in divided doses. The usual adult dose is 1 g/day in divided doses every 6 hours.

Children:

The recommended daily dosage for children is 25 to 50 mg/kg/day in divided doses every 6 hours.

Overdose:

Symptoms of oral overdose may include:

  • nausea
  • vomiting
  • abdominal pain
  • diarrhea
  • bloody urine
If you think you have taken too much KEFLEX®, contact your healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms.

What are possible side effects from using KEFLEX®?

These are not all the possible side effects you may feel when taking KEFLEX®. If you experience any side effects not listed here, contact your healthcare professional.

You may experience diarrhea, nausea, vomiting, loose stools, abdominal pain, diaper rash, inflammation of the vagina or discharge, dizziness, fatigue, headache, agitation, confusion, hallucinations or symptoms that you do not understand. You should tell your health professional for of any of these symptoms as soon as possible.

Vertigo (loss of balance or unsteadiness), tinnitus (ringing in the ears), hearing loss and behavioural changes in young children have been reported.

KEFLEX® may also cause effects such as yellowing of the whites of the eyes or skin (jaundice) or the inflammation of the liver (hepatitis).

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
RARE

Symptoms of a severe bowel condition (Clostridium difficile colitis):

  • persistent diarrhea
  • bloody or watery diarrhea
  • abdominal or stomach pain/cramping
  • blood/mucus in stool
✓

Severe skin reactions:

  • skin rash, which may blister, and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge)
  • widespread rash with blisters and skin peeling on much of the body surface particularly around the mouth, nose, eyes and genitals.
✓

Severe Cutaneous Adverse Reactions (SCAR) (severe skin reactions that may also affect other organs):

  • Skin peeling, scaling, or blistering (with or without pus) which may also affect your eyes, mouth, nose or genitals, itching, severe rash, bumps under the skin, skin pain, skin color changes (redness, yellowing, purplish)
  • Swelling and redness of
✓
  • eyes or face
  • Flu-like feeling, fever, chills, body aches, swollen glands, cough
  • Shortness of breath, chest pain or discomfort

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

Tablets:

Store between 15°C and 30°C. Keep tightly closed.

Oral Suspension:

Store dry powder between 15°C and 30°C. Suspension may be kept for 14 days in a refrigerator without significant loss of potency.

Keep tightly closed. Shake well before using.

If you want more information about KEFLEX®:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); or by calling the manufacturer at 1-888-550-6060.

    PENDOPHARM, Division de/of Pharmascience Inc.

    Montréal Canada

    H4P 2T4

Last revised: March 17, 2020

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 00015547

Revision date stated in the text: March 17, 2020

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Keflex

Rx or OTC
Prescription (Rx)?
DIN 00015547, 00035645, 00244392, 00403628
Schedule(s) PRESCRIPTION
Active ingredient(s) Cephalexin
Dosage form(s) Powder For Suspension, Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. J Antiinfectives for systemic use
    1. J01 Antibacterials for systemic use
      1. J01D Other beta-lactam antibacterials
        1. J01DB First-generation cephalosporins
          1. J01DB01 Cefalexin
Company PENDOPHARM DIVISION OF PHARMASCIENCE INC
Current status Dormant
Strengths and forms
DIN Strength Dosage form(s) Current status
00015547 125 MG Powder For Suspension Dormant August 3, 2017
00035645 250 MG Powder For Suspension Dormant August 2, 2018
00244392 500 MG Tablet Dormant August 3, 2017
00403628 250 MG Tablet Dormant August 3, 2017

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.